CD49d expression is included in a revised 4-factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real-world experience.
Bomben R, Zucchetto A, Laureana R, Chiarenza A, Olivieri J, Tissino E, Rossi FM, Vit F, Bittolo T, Papotti R, Pozzo F, Gaglio A, Degan M, Polesel J, Marasca R, Visentin A, Moia R, Innocenti I, Vitale C, Murru R, Varettoni M, Tafuri A, Zaja F, Postorino M, Martino EA, Condoluci A, Rossi D, Cuneo A, Di Raimondo F, Sportoletti P, Del Giudice I, Foà R, Mauro FR, Coscia M, Laurenti L, Gaidano G, Trentin L, Principe MID, Gentile M, Gattei V.
Bomben R, et al. Among authors: laurenti l.
Hemasphere. 2024 Jul 15;8(7):e128. doi: 10.1002/hem3.128. eCollection 2024 Jul.
Hemasphere. 2024.
PMID: 39011128
Free PMC article.
No abstract available.